Bristol-Myers Squibb Company (
) will begin trading ex-dividend on April 03, 2013. A cash dividend
payment of $0.35 per share is scheduled to be paid on May 01, 2013.
Shareholders who purchased BMY stock prior to the ex-dividend date
are eligible for the cash dividend payment. This represents an
2.94% increase over the same period a year ago. At the current
stock price of $41.14, the dividend yield is 3.4%.
The previous trading day's last sale of BMY was $41.14,
representing a -0.53% decrease from the 52 week high of $41.36 and
a 34.27% increase over the 52 week low of $30.64.
BMY is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). BMY's current earnings per share, an indicator of a company's
profitability, is $1.15. Zacks Investment Research reports BMY's
forecasted earnings growth in 2013 as -8.4%, compared to an
industry average of -.1%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to BMY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have BMY as a top-10 holding:
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- PowerShares Dynamic Pharmaceuticals (
- Merrill Lynch Pharmaceutical HOLDRS (
- SPDR S&P Pharmaceuticals ETF (
- First Trust Morningstar Dividend Leaders Index Fund (
The top-performing ETF of this group is PJP with an increase of
15.98% over the last 100 days. IHE has the highest percent
weighting of BMY at 6.34%.